May of 1999 and July of 1999, and the findings reveal that HIV knowledge was not high in this population despite the prevalence of high education. Although it was observed that most women (98%) knew that HIV could be transmitted through sex with an HIV-infected person and that HIV causes AIDS, myths about prevention were common. Over two-thirds of the sample (68.5%) believed that monogamy was an effective means of preventing HIV, 20.1% believed that using a diaphragm could prevent infection, and 11.6% believed that a spermicide alone could protect them from HIV infection. A significant number of women also had misconceptions about HIV transmission. Over one-third of the sample (37.8%) believed that HIV could be transmitted by blood donation, 16.8% believed that HIV could be transmitted by public toilets, 15.5% believed that mosquito bites transmit the virus, and 10.8% believed that sharing utensils with an HIV-positive person could transmit HIV infection.
DISCUSSION:
The HIV/AIDS awareness findings of this study suggest that the women in this study have a limited knowledge base. Health care providers who serve South Asian immigrant populations must be aware of and understand their social and cultural beliefs. It is essential to study the dynamics of knowledge and attitudes regarding AIDS amongst women in immigrant communities, and how this will reflect on the care provided to them and the subsequent success of treatment. False beliefs concerning AIDS and HIV transmissions can lead to lifestyle changes that will affect these women and their families. It has been observed that the only variable to correlate positively with knowledge has been education. To help South Asian women better understand the risks of sexual activity and how to protect themselves, HIV and sexually transmitted disease education programs for South Asian women should have a high priority for health care professionals.
more PTSD symptoms than mothers of full-term, healthy infants. Quinell (1995) replicated earlier findings by DeMier and by DeMier et al. All of the aforementioned studies found that the severity of neonatal complications was the primary predictor of PTSD symptomatology in parents. Quinell also evaluated the PPQ's convergent and divergent construct validity. The PPQ was found to have moderately high correlations with both convergent measures selected for study, whereas no correlation was found between the PPQ and the divergent measure. The current study further addresses the validity of the PPQ as a measure of PTSD in parents of high-risk infants. This study replicates Quinnell's procedures by using one of the same convergent validity measures. Construct validity is further examined with a new convergent measure and a new divergent measure. In addition, Quinnell examined construct validity through a retrospective design, whereas the current study uses a prospective design. RESEARCH QUESTION: Based on Quinnell's (1995) findings and the literature review, the following hypotheses were generated. Mothers of high-risk infants (gestational age of Յ37 weeks or complications such as apnea, bradycardia, etc. or more severe complications) will endorse more items on the PPQ and convergent measure (the Impact of Event Scale [IES]) than mothers of healthy, full-term infants. Mothers in the two groups will not significantly differ on their scores on the divergent measure. All of the convergent measures selected for study share variance that is attributable to general psychological distress. As a result, moderate correlations are expected between the PPQ and the Beck Depression Inventory-Second Edition (BDI-II) as well as between the IES and BDI. The PPQ and IES will also share additional variance attributable to the specific symptoms of PTSD. Therefore, a high correlation is expected between the PPQ and the IES. Because the divergent measure does not measure either general psychological distress or PTSD sequelae, no significant correlation is expected between it and the other measures. Finally, the severity of the infant's postnatal complications, birth weight, gestational age, and length of hospital stay are expected to be related to the endorsement of items on the PPQ.
METHODS: A survey composed of several sections was created. The first section of the survey collected demographic information about both of the infant's biological parents as well as general information regarding the infant's birth and hospitalization. The next component examined the complications the infant experienced postnatally. The PPQ comprised the next section of the survey. The IES, a reliable and valid measure of PTSD, was included in the survey as a convergent measure. The Openness scale appeared next in the survey to establish divergent validity. The Openness scale measures an individual's openness to experience and has excellent psychometric properties. The last section of the survey consisted of the BDI-II. The BDI-II is a measure of the severity of depression, with excellent psychometric properties, and has been widely used in research. The BDI-II was chosen as a second convergent measure due to the considerable research linking depression and PTSD. Data were collected by posting the survey on the internet and also distributing it in undergraduate psychology courses at the University of Wisconsin-Milwaukee.
RESULTS:
A total of 170 surveys were submitted. Only cases in which (1) the mother completed the survey, (2) the child survived, and (3) no more than 2 years had elapsed between the child's delivery and the completion of the survey were selected for data analyses (N ϭ 88). Mothers of high-risk infants scored higher on the PPQ (M ϭ 21.45) than mothers of healthy, full-term infants (M ϭ 16.90), but this difference was not significant. Similarly, mothers of high-risk infants scored higher on the IES (M ϭ 17.6) than mothers of fullterm, healthy infants (M ϭ 8.9), but this difference was also not significant. Mothers of the two groups did score significantly different on the BDI-II (F ϭ 9.65, p Ͻ 0.05). No significant difference between groups was found for scores on the Openness scale. Significant positive correlations were found between the PPQ and the IES (r ϭ 0.48, p Ͻ 0.001), between the PPQ and the BDI-II (r ϭ 0.67, p Ͻ 0.001), and between the IES and the BDI-II (r ϭ 0.36, p Ͻ 0.001). No correlation was found between the Openness scale and the other measures. A hierarchic multiple regression analysis was performed using PPQ scores as the criterion. The following were entered first as the control variables: mother's age at the time of giving birth, mother's age at the time of completing the survey, mother's parity, maternal socioeconomic status, and paternal socioeconomic status. Together these variables accounted for Ͻ10% of the variance in PPQ scores. The perinatal stressors were then entered into the equation after the control variables (in order of largest to smallest univariate correlation). Only the infant's birth weight significantly increased the predictability of PTSD symptomatology on the PPQ by accounting for 32% of the variance (multiple r ϭ 0.57, F(6,77) ϭ 6.05, p Ͻ 0.001).
DISCUSSION: The PPQ is significantly correlated with both the IES and the BDI-II. Furthermore, the IES and the BDI-II are significantly correlated. None of the convergent measures is significantly correlated with the Openness scale. Specific perinatal stressors (e.g., birthweight) are significantly related to the development of PTSD symptoms. This may allow for early identification of at-risk mothers so that interventions can take place quickly and mitigate the effects of a high-risk birth. This study is unlike all previous findings in that no significant group differences between mothers of high-risk infants and mothers of healthy, full-term infants were found on either PPQ scores or IES scores. One possibility is that mothers of high-risk infants are more prone to delayed onset PTSD and the current prospective design has not allowed for enough time to elapse for the onset of PTSD to occur in these women. Further research is needed to determine the nature of this discrepancy.
Distribution of Maternal/Fetal Medicine Specialists in the United States
David E. Gagnon, President; Rachel M. Schwartz, Vice President National Perinatal Information Center The American Board of Obstetrics and Gynecology has established the subspecialty of maternal/fetal medicine (MFM) in 1972. Since that time, the number of subspecialists has increased to almost 1500 (1459) 1 board-eligible and board-certified maternal/fetal specialists. Over the past two decades, the distribution and activity of these physicians have changed dramatically. To understand these changes, the Society of Maternal Fetal Medicine contracted with the National Perinatal Information Center in 1998 to conduct an extensive survey of the specialty. One aspect of this survey included the distribution of the physician population across the United States. This study is the result of that activity.
Because these specialists concentrate in urban areas, we used the 328 Metropolitan Statistical Areas (MSAs) and Primary Metropolitan Statistical Areas (PMSAs) as the geographic base for assessing the distribution of MFM (MSAs and PMSAs are urban areas with a population Ͼ50,000). Also, because these physicians relate to high-risk births and the percentage of high-risk births relates to volume of births, we related the number of physicians to the number of births in each MSA and PMSA.
In 1997, 82% 2 of all births in the United States occurred in an MSA. Similarly, almost all physicians surveyed resided and worked in a given MSA, with the exception of 15 physicians located in identifiable rural areas.
Using a population model derived from the 1990 census and inter-censal birth projections by county, we projected births for 1997, 2000, 2005, and 2010 in each MSA and PMSA. Also, using zip codes as the reference, we assigned physicians to their respective MSA or PMSA. We identified a national rate of 0.375 MFM physicians/1000 births. Using this as the standard, we first identified the census division with more or less MFM physicians related to number of births. (There are nine census divisions in the United States.) We found the heaviest concentration of MFM specialists in census division 2 (NJ, NY, PA) and the lowest concentration in census division 5 (AL, KY, MS, TN) and census division 7 (AR, LA, OK, TX).
If we assume the national rate as a standard for the apportionment of MFMs, we can project that an MSA requires ϳ3000 births or more to justify an MFM specialist. In the United States, there are 33 MSAs with this birth cohort level that currently do not have an MFM specialist. There are, however, 19 MSAs and PMSAs with higher ratios of MFM specialists to births (Ͼ1/3000 births). In contrast to those MSAs with Ͼ3000 births and no MFM specialists, we count only 29 MSAs with Ͻ3000 births that have one or more MFM specialists. There are 9758 births in the average MSA and an average of 4.4 MFM physicians in each MSA if they were evenly distributed. Because this is not the case, the distribution of these specialized physicians occurs in a random fashion governed more by the presence of an academic teaching program and/or concentration of population. As competition between specialists and between primary care physicians and specialists intensifies, there should be a trend of greater distribution across MSAs.
Although this analysis does not assess need, we can ascertain the present mal-distribution of these specialists across MSAs. Concentration of MFM specialists in the urban areas of the Northeast, Middle Atlantic, East North Central, and Pacific is likely to continue because these regions have the heaviest concentration of fellowship programs and population.
There is a need to relate the MFM specialist to births based on interventions in high-risk pregnancies that result in improved outcome. We intend to develop such a study as a result of our recent survey.
Increased Bronchopulmonary Dysplasia (BPD) and
Death Postponement: The Prices of Success for Reduced Mortality in the Postsurfactant Era K. Wright Department of Pediatrics, University of Tennessee Graduate School of Medicine, Knoxville, TN. OBJECTIVE: To determine changes in morbidity and mortality of ventilated, extremely low birth weight infants after the introduction of surfactant therapy in 1990.
STUDY DESIGN/SETTING: Retrospective/tertiary neonatal intensive care unit.
PATIENTS: All ventilated patients born 1/1/84 to 12/31/97 with a birth weight of Յ1000 (N ϭ 623).
METHODS: Primary outcomes included mortality, length of stay, and survival without bronchopulmonary dysplasia (BPD) (oxygen or ventilator dependence at 28 days postnatal age or 36 weeks postmenstrual age).
RESULTS: Pre-and postsurfactant patients were well matched, with no significant differences in gestational age, birth weight, Apgar (Figure 1 ). For survivors, both length of stay and oxygen and ventilator days increased in the postsurfactant period, as did the incidence of bacteremia and BPD. The likelihood of discharge on home oxygen also increased 12-fold in the postsurfactant period. Yearly changes in mortality and survival with and without BPD are shown in Figure 2 . Note the abrupt increase in the proportion of survivors with BPD coincident with the advent of surfactant therapy in 1990. Although the median age at death for nonsurvivors in both time periods was 24 to 48 hours, this median does not accurately reflect the increased number of "late" deaths in the postsurfactant time period. Whereas 90% of presurfactant infants expired by 3 weeks of age, 90% of postsurfactant deaths did not occur until 7 weeks of age ( p ϭ 0.002). This delay in postsurfactant deaths is shown in Figure  3 , a plot of cumulative mortality versus length of stay. Cost-effectiveness ratios (the additional days of resource use per additional survivor) for length of stay and oxygen and ventilator days all increased in the postsurfactant period (Figure 4) .
CONCLUSIONS:
The benefits of mortality reduction in the postsurfactant era may be offset by increasing respiratory morbidity in some survivors, and by an unwelcome prolongation of death for some nonsurvivors. We speculate that the ultimate costs of these undesirable outcomes may greatly surpass the ostensible cost benefits of neonatal surfactant therapy.
Neurologic and Neurodevelopmental Outcome of Marked
Neonatal Hyperbilirubinemia During Infancy Raja Nandyal, MD; Shana Beaver, PAS II; Wendy Becker, PAS II; Lesa Orlando, PAS II; Laura Spiedel, PAS II; Russ Kirby, PhD, MS, FACE; and Saralyn Byker, PA-C INTRODUCTION: Recently, kernicterus and other types of bilirubin-induced (related) neurologic dysfunction in infants who were born apparently healthy at term or near term have reappeared. Following the national trend, we have also seen in Racine and Kenosha counties a marked increase in the number of neonates with total serum bilirubin (TSB) of Ն20 mg/dl and also neonates who needed exchange transfusion.
OBJECTIVE: This study was done to test the hypothesis that TSB of Ն20 mg/dl in otherwise healthy term or near-term neonates with a birth weight of Ն2500 gm does not result in neurodevelopmental delay or neurologic compromise during the first year of life.
METHODS/STUDY DESIGN:
A retrospective review of charts was done. Infants that were included were born between August 1, 1995 and July 31, 1998, admitted for the management of marked hyperbilirubinemia, and later followed at our HOPE Clinic (Healthy Outcome for Premature and Every child-a multidisciplinary highrisk follow-up clinic), during their infancy. Inclusion criteria were as follows: TSB of Ն20 mg/dl, postconceptional (gestational) age of Ն36 weeks, and a birth weight of Ն2500 gm. Exclusion criteria were as follows: A list of maternal or fetal disease processes or physiological insults that can cause jaundice. RESULTS/DISCUSSION: Of the 28 children (n ϭ 28) studied (TSB range of 20 to 48 mg/dl), 11 infants (39.3%) had at least one double volume exchange transfusion. A total of 25 infants (89.3%) were mainly breast fed (21 infants [75%] exclusively), before hospitalization. With the exception of 1 infant (breast fed), all others (96.4%) had at least one of the following factors known to be associated with jaundice: weight loss of 5% to 12% (17 or 60.7%); gestational age of 36 to 38 weeks (12 or 42.8%); blood group incompatibility (9 or 32.1%); and miscellaneous (7 or 25%), including cephalohematoma, bruising, gestational diabetes, polycythemia, L.G.A., G6PD deficiency, etc. A total of 13 infants (46.4%) had two or more factors. Transient neuromuscular and/or developmental problems were noted in nine infants (32.1%) at 3 to 4 months of age (cor- rected to prematurity). In another three children (10.7%), significant neurodevelopmental problems persisted at 8 to 15 months of age (corrected). Interestingly, we noted gastroesophageal reflux in five children (17.8%).
CONCLUSION:
We noted that marked hyperbilirubinemia can be anticipated in a breast-fed near-term or term infant with weight loss of Ն5% when associated with ABO incompatibility, polycythemia, extravasated blood, or related conditions. We strongly recommend that these infants be followed closely. Approximately one-third of our children showed transient neurodevelopmental concerns at 3 to 4 months of age, and another 10% had significant neurodevelopmental problems even at 8 to 15 months of corrected age. None of our children developed kernicterus. Based on our experience, we strongly recommend being VIGINTI-VIGILANT ( Women who use cocaine during pregnancy differ from nonusers in ways that promote adverse pregnancy outcomes. The intent of this study was (1) to identify a profile of risk behaviors among cocaine using prenatal patients and (2) to evaluate pregnancy outcomes by studying all identifiable variables. The study design was case control. For each variable, the null hypothesis was that cocaine using mothers were not different from the control group.
Variables were analyzed by comparing cocaine-exposed mothers to a matched unexposed patient. For discrete variables, -squared and odds ratios with 95% confidence limits were calculated. Continuous and ordinate data were compared by nonparametric Wilcoxon rank sums. Logistic regression was performed including variables found to be different between study and control patients with end points of low birth weight and preterm delivery. Sample size was derived on the assumption that the prevalence of low birth weight was 20% in study patients and 10% in control patients. To achieve a power of 0.8 with significance at 0.05, 141 patients were needed in each group. In reality, 147 were studied in each group.
The uniqueness of this study resides in an assessment of the multitude of social and medical problems that may be encountered in an antepartum setting rather than in the more frequently studied intrapartum setting. We found that cocaine use was associated with older, multiparous women who were unmarried and who had a history of prior low birth weight babies. Prenatal care was obtained later and visits were less frequent. Other substances, including tobacco, alcohol, and marijuana were more commonly used. A history of physical abuse and violence as well as incarceration were identified more often. The prevalence of syphilis was higher, cocaine-using women delivered earlier, and prematurity occurred more often. Their infants were smaller. Regression analysis identified factors other than cocaine as important in either the low birth weight or preterm delivery. Attainment of more prenatal visits by the using mothers was associated with improved outcome.
The number and extent of behaviors and disorders identified with cocaine use indicate that chaos is present. CHAOS may serve as an acronym, highlighting components of the protean difficulties encountered when working with cocaine-using pregnant women. C stands for Cocaine. H represents poor Health-seeking behavior. A identified Abuse, reflected of the violence that permeates the lives of these women. O indicates Older or multiparous women. S calls attention to the high occurrence of Syphilis. A second acronym may also be constructed. C is for Cigarette smoking. H is for History of incarceration. A represents Alcohol consumption. O marks Obstetric history of low birth weight. S focuses on marital Status.
Chaos cannot be controlled, but the environment in which it exists can be altered. Attempts to completely modify an individual's lifestyle are difficult to achieve during pregnancy. Small, limited steps encouraging, and supporting prenatal care utilization, adequate weight gain, use of prenatal vitamins and iron, treatment of infections, and management of medical disorders may be sufficient to improve outcomes. Labeling a woman solely as a cocaine abuser overlooks and undervalues the plethora of frequently occurring and significant associated social and medical ills. Application of the CHAOS acronyms may assist in conceptualization of the many disorganized aspects of their lives.
